Loading...

Medibio Partners with Digital Corporate Wellness Solution Leader WellteQ

Highlights ● Medibio and WellteQ will work together to implement a unique digital solution incorporating Medibio’s mental well-being assessment into WellteQ’s personalised and holistic wellness platform. ● WellteQ is an award-winning digital wellness solution for personalised health engagement and [...]

2019-07-29T14:03:45-05:00 July 29th, 2019|

Medibio Signs Global Organisation, Compass Group PLC, for the First of Two UK-based Pilots for ilumen™

Highlights: ● Compass employees in its Business and Industry division in the United Kingdom will take part in the ilumen™ well-being pilot commencing in July. ● ilumen™ will provide participants with access to a mobile and web application for [...]

2019-07-01T13:31:52-05:00 July 1st, 2019|

Medibio Algorithm Validated by Study Published in Peer Reviewed Journal

Highlights: ● This study demonstrates that changes in heart rate across sleep-wake states may be valid physiological markers for the identification of depression in a sample of people with sleep complaints. ● The heart rate profiling algorithm classified individuals [...]

2019-06-20T10:20:59-05:00 June 20th, 2019|

Medibio working with DuVal & Associates on Updated Regulatory Strategy

Medibio Announces Regulatory and Commercialisation Strategy Update Melbourne, Australia and Minneapolis, MN – 30 April 2019: Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company provides the following update on regulatory strategy. Effective 29 April, [...]

2019-06-20T10:23:08-05:00 May 16th, 2019|

Medibio Announces Sponsored Research Agreement with Humanitas University

Melbourne, Australia and Minneapolis, MN – 17 April 2019: Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company today announces a Sponsored Research Agreement with the Department of Biomedical Sciences of Humanitas University, Milan, Italy. [...]

2019-05-16T16:12:29-05:00 April 17th, 2019|

Medibio Signs Insurance Company AIA Australia Ltd (AIAA) For an Exclusive Pilot Program For ilumen™

Sydney, Australia and Minneapolis, MN USA – 27 November 2018: Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company announces that it has signed an exclusive agreement with AIAA to undertake a pilot program for [...]

2019-03-13T13:59:54-05:00 November 26th, 2018|

Medibio Appoints Global Healthcare & Medical Device Leader as CEO and Managing Director

Medibio Appoints Global Healthcare & Medical Device Leader as CEO and Managing Director   Sydney, Australia and Minneapolis, MN USA – 2 November 2018: Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company, announces the [...]

2019-03-13T14:01:00-05:00 November 1st, 2018|

Medibio Technology Honored with Two Presentations at Mayo Clinic Convergence Neuroscience 2018

Sydney, Australia and Minneapolis, MN USA – 8 October 2018: Medibio Limited (MEB or the Company)(ASX: MEB)(OTCQB: MDBIF), a mental health technology company, is happy to announce that two clinical abstracts by Dr. Archie Defillo et al. have been [...]

2018-10-07T19:31:02-05:00 October 7th, 2018|